64Trust
Partially True
🔍 Web Verified🔍 Search Verified
Prof Peter Hotez MD PhD DSc(hon)onX / Twitter2d ago
So MAHA is not happy that by debunking their pseudoscience, I hurt the sales of their ivermectin, hydroxychloroquine, fenbendazole, which they purchase in bulk, repackage, and sell to you after they jack up the price or pair it with an expensive telehealth visit. I’m bad for business
Trust Metrics
72
58
55
62
Accuracy72%
Framing58%
Context55%
Tone62%
Analysis Summary
Hotez claims MAHA (a medical advocacy group) profits by bulk-purchasing and reselling ivermectin and hydroxychloroquine at markups, and that his debunking of these drugs' effectiveness has harmed their sales. The core claim about MAHA's business model cannot be independently confirmed; major health authorities have found insufficient evidence supporting these drugs for COVID-19, but Hotez presents this as established fact without citing specific rebuttals to MAHA's position. The post frames the relationship as profit-driven hostility rather than genuine scientific disagreement.
Claims Analysis (3)
“MAHA purchases ivermectin, hydroxychloroquine, fenbendazole in bulk, repackages them, and sells them at marked-up prices”
No independent confirmation of MAHA's bulk purchasing or repackaging practices found in available sources.
“Hotez's debunking of these treatments has hurt MAHA's sales”
No evidence available connecting Hotez's statements to MAHA sales impact.
“Ivermectin and hydroxychloroquine are pseudoscience for their promoted uses”
FDA and major health authorities have found insufficient evidence for these drugs in COVID-19 treatment, though debate continues in some circles.
Was this analysis helpful?
Try ClearFeed free →